RADIOLIGAND THERAPY IN LYMPHOMA: PAST, PRESENT AND FUTURE
Summary: In the 80s, radiolabeled cells helped understand the pathology of hemato-oncology. In the 90s, pre-clinical trials evaluated radiolabeled immunotherapy with monoclonal antibodies (MoAbs) such as anti-CD20 agents labeled with Iodine-131 (Bexxar®) or Yttrium-90 (Zevalin®). Due to the safe and...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2024-04-01
|
| Colecção: | Hematology, Transfusion and Cell Therapy |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2531137924001974 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|